Pharmacotherapy in cancer patients with HIV/AIDS.

Beumer, J H; Venkataramanan, R; Rudek, M A

Beumer, J H; Venkataramanan, R; Rudek, M A.

Affiliation

Beumer JH; 1] Molecular Therapeutics and Drug Discovery Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA [2] Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Venkataramanan R; 1] Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA [2] Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Rudek MA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.

Clin Pharmacol Ther ; 95(4): 370-2, 2014 Apr.

Article in En | MEDLINE | ID: mdl-24440966

Subject(s)

Acquired Immunodeficiency Syndrome/drug therapy; Anti-HIV Agents/therapeutic use; Antineoplastic Agents/therapeutic use; HIV Infections/drug therapy; Neoplasms/drug therapy; Acquired Immunodeficiency Syndrome/epidemiology; Acquired Immunodeficiency Syndrome/physiopathology; Anti-HIV Agents/administration & dosage; Antineoplastic Agents/administration & dosage; Dose-Response Relationship, Drug; Drug Interactions; HIV Infections/epidemiology; HIV Infections/physiopathology; Humans; Life Expectancy; Neoplasms/epidemiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Acquired Immunodeficiency Syndrome / Anti-HIV Agents / Neoplasms / Antineoplastic Agents Type of study: Guideline Aspects: Patient_preference Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2014 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google